By Samantha Lane (Drug Safety Research Unit [DSRU])2023-12-14T10:00:09
Samantha Lane, Head of Research for the Centre of Pharmacovigilance Sciences at the Drug Safety Research Unit discusses drug product withdrawals and the regulatory shift to a greater reliance on epidemiological and observational research as evidence for these decisions within Europe.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2027-01-27T15:00:00Z
Sponsored by Cell Signaling Technology
2026-11-19T09:05:00Z
Sponsored by PCI Pharma Services
2026-10-19T13:13:00Z
2026-06-30T10:37:00
Sponsored by Bruker (SciY), By European Pharmaceutical Review
2026-09-23T12:28:00
Sponsored by Pfizer CentreOne and Lubrizol Advanced Materials Europe BV, By European Pharmaceutical Review
2026-08-20T08:05:00
Sponsored by Sartorius
2026-10-14T14:00:00
Sponsored by Particle Measuring Systems
2026-09-16T15:00:00
Sponsored by BioDuro
Site powered by Webvision Cloud